EP1870422 - Means for the treatment of diseases characterized by an excessive immune reaction [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.11.2008 Database last updated on 06.11.2024 | Most recent event Tooltip | 21.11.2008 | Application deemed to be withdrawn | published on 24.12.2008 [2008/52] | Applicant(s) | For all designated states SuppreMol GmbH Am Klopferspitz 19 82152 Martinsried / DE | [2007/52] | Inventor(s) | 01 /
Jacob, Uwe Guldeinstrasse 42 80339 Munich / DE | [2007/52] | Representative(s) | Bohmann, Armin K. Bohmann Anwaltssozietät Nymphenburger Strasse 1 80335 München / DE | [N/P] |
Former [2007/52] | Bohmann, Armin K. Bohmann & Loosen Anwaltssozietät Nymphenburger Strasse 1 80335 München / DE | Application number, filing date | 06012684.4 | 20.06.2006 | [2007/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1870422 | Date: | 26.12.2007 | Language: | EN | [2007/52] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 24.10.2006 | Classification | IPC: | C07K16/28, A61P37/00, C12N15/13, A61K39/00 | [2007/52] | CPC: |
C07K16/283 (EP);
A61P37/00 (EP);
A61K2039/505 (EP)
| Designated contracting states | (deleted) [2008/36] |
Former [2007/52] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Mittel zur Behandlung von Erkrankungen, die durch eine übermässige Immunreaktion gekennzeichnet sind | [2007/52] | English: | Means for the treatment of diseases characterized by an excessive immune reaction | [2007/52] | French: | Moyens pour le traitement de maladies caractérisées par une réaction immunitaire excessive | [2007/52] | Examination procedure | 27.06.2008 | Application deemed to be withdrawn, date of legal effect [2008/52] | 06.08.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2008/52] | Fees paid | Penalty fee | Additional fee for renewal fee | 30.06.2008 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [AD]WO2004016750 (MACROGENICS INC [US], et al) [AD] 1-28 * page 12, line 12 - line 34 * * page 13, line 28 - line 33 *; | [XD]WO2005051999 (MAX PLANCK GESELLSCHAFT [DE], et al) [XD] 1-28 * page 8, line 11 - line 25; figure 1 * * page 9, line 5 - line 8 * * page 13, line 6 - line 21 * * page 20, line 30 - line 34 *; | [A]WO2006028956 (GENENTECH INC [US], et al) [A] * the whole document *; | [A] - NAKAMURA AKIRA ET AL, "Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer.", EXPERT OPINION ON THERAPEUTIC TARGETS. FEB 2005, (200502), vol. 9, no. 1, ISSN 1744-7631, pages 169 - 190, XP009073504 [A] * the whole document * DOI: http://dx.doi.org/10.1517/14728222.9.1.169 |